Advancing Glioblastoma Research with Innovative Brain Organoid-Based Models
Glioblastoma (GBM) is a relatively rare but highly aggressive form of brain cancer characterized by rapid growth, invasiveness, and resistance to standard therapies. Despite significant progress in understanding its molecular and cellular mechanisms, GBM remains one of the most challenging cancers t...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Cells |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/14/4/292 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850081896174714880 |
|---|---|
| author | Cátia D. Correia Sofia M. Calado Alexandra Matos Filipa Esteves Ana Luísa De Sousa-Coelho Marco A. Campinho Mónica T. Fernandes |
| author_facet | Cátia D. Correia Sofia M. Calado Alexandra Matos Filipa Esteves Ana Luísa De Sousa-Coelho Marco A. Campinho Mónica T. Fernandes |
| author_sort | Cátia D. Correia |
| collection | DOAJ |
| description | Glioblastoma (GBM) is a relatively rare but highly aggressive form of brain cancer characterized by rapid growth, invasiveness, and resistance to standard therapies. Despite significant progress in understanding its molecular and cellular mechanisms, GBM remains one of the most challenging cancers to treat due to its high heterogeneity and complex tumor microenvironment. To address these obstacles, researchers have employed a range of models, including in vitro cell cultures and in vivo animal models, but these often fail to replicate the complexity of GBM. As a result, there has been a growing focus on refining these models by incorporating human-origin cells, along with advanced genetic techniques and stem cell-based bioengineering approaches. In this context, a variety of GBM models based on brain organoids were developed and confirmed to be clinically relevant and are contributing to the advancement of GBM research at the preclinical level. This review explores the preparation and use of brain organoid-based models to deepen our understanding of GBM biology and to explore novel therapeutic approaches. These innovative models hold significant promise for improving our ability to study this deadly cancer and for advancing the development of more effective treatments. |
| format | Article |
| id | doaj-art-e65c18c4a0494f7dbff9848a3a28c037 |
| institution | DOAJ |
| issn | 2073-4409 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Cells |
| spelling | doaj-art-e65c18c4a0494f7dbff9848a3a28c0372025-08-20T02:44:38ZengMDPI AGCells2073-44092025-02-0114429210.3390/cells14040292Advancing Glioblastoma Research with Innovative Brain Organoid-Based ModelsCátia D. Correia0Sofia M. Calado1Alexandra Matos2Filipa Esteves3Ana Luísa De Sousa-Coelho4Marco A. Campinho5Mónica T. Fernandes6Algarve Biomedical Center Research Institute (ABC-RI), Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, PortugalAlgarve Biomedical Center Research Institute (ABC-RI), Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, PortugalAlgarve Biomedical Center Research Institute (ABC-RI), Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, PortugalAlgarve Biomedical Center Research Institute (ABC-RI), Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, PortugalAlgarve Biomedical Center Research Institute (ABC-RI), Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, PortugalAlgarve Biomedical Center Research Institute (ABC-RI), Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, PortugalAlgarve Biomedical Center Research Institute (ABC-RI), Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, PortugalGlioblastoma (GBM) is a relatively rare but highly aggressive form of brain cancer characterized by rapid growth, invasiveness, and resistance to standard therapies. Despite significant progress in understanding its molecular and cellular mechanisms, GBM remains one of the most challenging cancers to treat due to its high heterogeneity and complex tumor microenvironment. To address these obstacles, researchers have employed a range of models, including in vitro cell cultures and in vivo animal models, but these often fail to replicate the complexity of GBM. As a result, there has been a growing focus on refining these models by incorporating human-origin cells, along with advanced genetic techniques and stem cell-based bioengineering approaches. In this context, a variety of GBM models based on brain organoids were developed and confirmed to be clinically relevant and are contributing to the advancement of GBM research at the preclinical level. This review explores the preparation and use of brain organoid-based models to deepen our understanding of GBM biology and to explore novel therapeutic approaches. These innovative models hold significant promise for improving our ability to study this deadly cancer and for advancing the development of more effective treatments.https://www.mdpi.com/2073-4409/14/4/292glioblastomabrain organoidsdisease modelsdrug discoveryhuman stem cellstumor heterogeneity |
| spellingShingle | Cátia D. Correia Sofia M. Calado Alexandra Matos Filipa Esteves Ana Luísa De Sousa-Coelho Marco A. Campinho Mónica T. Fernandes Advancing Glioblastoma Research with Innovative Brain Organoid-Based Models Cells glioblastoma brain organoids disease models drug discovery human stem cells tumor heterogeneity |
| title | Advancing Glioblastoma Research with Innovative Brain Organoid-Based Models |
| title_full | Advancing Glioblastoma Research with Innovative Brain Organoid-Based Models |
| title_fullStr | Advancing Glioblastoma Research with Innovative Brain Organoid-Based Models |
| title_full_unstemmed | Advancing Glioblastoma Research with Innovative Brain Organoid-Based Models |
| title_short | Advancing Glioblastoma Research with Innovative Brain Organoid-Based Models |
| title_sort | advancing glioblastoma research with innovative brain organoid based models |
| topic | glioblastoma brain organoids disease models drug discovery human stem cells tumor heterogeneity |
| url | https://www.mdpi.com/2073-4409/14/4/292 |
| work_keys_str_mv | AT catiadcorreia advancingglioblastomaresearchwithinnovativebrainorganoidbasedmodels AT sofiamcalado advancingglioblastomaresearchwithinnovativebrainorganoidbasedmodels AT alexandramatos advancingglioblastomaresearchwithinnovativebrainorganoidbasedmodels AT filipaesteves advancingglioblastomaresearchwithinnovativebrainorganoidbasedmodels AT analuisadesousacoelho advancingglioblastomaresearchwithinnovativebrainorganoidbasedmodels AT marcoacampinho advancingglioblastomaresearchwithinnovativebrainorganoidbasedmodels AT monicatfernandes advancingglioblastomaresearchwithinnovativebrainorganoidbasedmodels |